| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 39 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 36 |
| 2 | TACROLIMUS OINTMENT 0.1% | 36 |
| 3 | MYCOPHENOLATE MOFETIL | 28 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 28 |
| 5 | PREDNISONE | 23 |
| 6 | RITUXIMAB | 14 |
| 7 | BASILIXIMAB | 13 |
| 8 | PREDNISOLONE | 13 |
| 9 | PREDNISOLONE ORAL | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MILTEFOSINE | 3 | 0.0077 |
| 1 | PYRIMETHAMINE | 6 | 0.0047 |
| 2 | FLUCYTOSINE | 3 | 0.0021 |
| 3 | BASILIXIMAB | 13 | 0.0011 |
| 4 | CLINDAMYCIN PHOSPHATE | 6 | 0.0011 |
| 5 | ATOVAQUONE | 7 | 0.0008 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 7 | 0.0008 |
| 7 | MYCOPHENILIC ACID | 7 | 0.0003 |
| 8 | AMPHOTERICIN B | 4 | 0.0003 |
| 9 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 6 | 0.0047 |
| 1 | Nucleoside Analog Antifungal [EPC] | 3 | 0.0021 |
| 2 | Sulfonamide Antibacterial [EPC] | 3 | 0.0008 |
| 3 | Antimalarial [EPC] | 7 | 0.0007 |
| 4 | Antiprotozoal [EPC] | 7 | 0.0007 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 7 | 0.0003 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 4 | 0.0002 |
| 8 | Penem Antibacterial [EPC] | 6 | 0.0002 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |